Download full-text PDF

Source

Publication Analysis

Top Keywords

suppression homograft
4
homograft immunity
4
immunity thiocymetin
4
suppression
1
immunity
1
thiocymetin
1

Similar Publications

Background: Maintenance immunosuppression is required for suppression of alloimmunity or allograft rejection. However, continuous use of immunosuppressants may lead to various side effects, necessitating the use of alternative immunosuppressive drugs. The early secreted antigenic target of 6 kDa (ESAT-6) is a virulence factor and immunoregulatory protein of mycobacterium tuberculosis (Mtb), which alters host immunity through dually regulating development or activation of various immune cells.

View Article and Find Full Text PDF

The antiausterity strategy in anticancer drug discovery has attracted much attention as a way to exterminate cancer cells under nutrient deprived conditions which are commonly found in solid tumors. These tumors under low nutrient stress are known to be malignant and often resist conventional drug therapy. As a potential drug candidate, we focused on the meroterpenoid natural product callistrilone O which has demonstrated extremely potent antiausterity properties toward PANC-1 pancreatic carcinoma in vitro.

View Article and Find Full Text PDF

Protective immune responses require close interactions between conventional (Tconv) and regulatory T cells (Treg). The extracellular mediators and signaling events that regulate the crosstalk between these CD4 T cell subsets have been extensively characterized. However, how Tconv translate Treg-dependent suppressive signals at the chromatin level remains largely unknown.

View Article and Find Full Text PDF

Ischemia-reperfusion injury (IRI) is the leading cause of hepatic graft dysfunction, resulting from hepatocyte damage. Nevertheless, given the few specialized therapeutics available in hepatic IRI, additional mechanistic insights into hepatocyte damage are required. Here, the protein solute carrier family 39 member 14 (SLC39A14) is identified as a pro-ferroptosis target in hepatocytes of human liver allografts through single-cell RNA sequencing analysis.

View Article and Find Full Text PDF

Novel conditioning and prophylaxis regimens for relapse prevention.

Hematology Am Soc Hematol Educ Program

December 2024

Division of Hematology, Department of Medicine and Surgery, University of Perugia, Italy.

Article Synopsis
  • Recent advancements in hematopoietic cell transplantation (HCT) for leukemia have improved safety and patient outcomes through better conditioning regimens and graft-versus-host disease management.
  • Despite these improvements, leukemia relapse remains a significant challenge, prompting research into its mechanisms and ways to enhance graft-versus-leukemia (GVL) effects.
  • The review highlights criteria for selecting donors that boost GVL activity, innovative conditioning approaches to reduce disease burden, and strategies to manipulate grafts for effective antileukemic action while minimizing immune suppression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!